Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: george who wrote (1054)	1/10/1998 4:58:00 PM
From: Cisco	Respond to of 1894

®I really do LOVE my computer, but I still would not want my Pap smear read by Neopath.¯ George, I don't know about you, but I don't even want a Pap smear!!! Cisco

To: george who wrote (1054)	1/10/1998 9:28:00 PM
From: Sigmund	Read Replies (2) \| Respond to of 1894

Neither my opinion, your opinion or my girlfriend's opinion counts. but I would like to know what the FDA advisory committee thinks. Their opinion is what counts. I think we should all understand that the current state of the art in Pap test automation is not for computers to make diagnosis or even to select slides for cytotechs to read but rather to select slides not to be read by cytotechs. When you are talking about a 25% reject rate this may not be particularly difficult. For some reason having a computer order slides by degree of liklihood that a cytotech needs to read it disturbs you but you have no problem with an automated Kirby-Bauer test. Can you explain why one bothers you and the other doesn't other than one might produce revenue for a company whose stock you own and the other might be seen as competition?